Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FOXO3 |
| Upstream (Parents) |
|---|
| (<<) SP140 → FOXO3 |
| (<<) HOXA2 → FOXO3 |
| (<<) NR2E3 → FOXO3 |
| (<<) MECOM → FOXO3 |
| (<<) PPARD → FOXO3 |
| (<<) FOSL2 → FOXO3 |
| (<<) PKNOX1 → FOXO3 |
| (<<) ZNF155 → FOXO3 |
| (<<) RARA → FOXO3 |
| (<<) SNAPC4 → FOXO3 |
| (<<) VAV1 → FOXO3 |
| (<<) NFYA → FOXO3 |
| Downstream (Children) |
|---|
| FOXO3 → EN2 (>>) |
| FOXO3 → PTH (>>) |
| FOXO3 → SCAND2 (>>) |
| FOXO3 → CREM (>>) |
| FOXO3 → NRL (>>) |
| FOXO3 → NKX2-5 (>>) |
| FOXO3 → NKX2-8 (>>) |
| FOXO3 → TBX4 (>>) |
| FOXO3 → SIX5 (>>) |
| FOXO3 → ZNF174 (>>) |
| FOXO3 → SRF (>>) |
| FOXO3 → RFX3 (>>) |
